Atossa Genetics is a clinical-stage pharmaceutical company focused on the development of novel therapeutics and delivery methods for the treatment of breast cancer and other breast conditions.
Atossa Genetics Announces Warrant Exercises
Atossa Genetics Receives Positive Safety Committee Assessment of First Cohort Receiving Oral Formulation of Endoxifen in Phase 1 Dose Escalation Study
Atossa Genetics to Present at the LD Micro Invitational on June 6, 2017
More Press Releases
Learn more about Atossa Genetics
Learn more about our programs
Contact Atossa Genetics today!